Applied DNA Sciences, Inc.

NasdaqCM:APDN Stock Report

Market Cap: US$5.5m

Applied DNA Sciences Management

Management criteria checks 4/4

Applied DNA Sciences' CEO is Clay Shorrock, appointed in Apr 2021, has a tenure of 4.5 years. total yearly compensation is $300.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0% of the company’s shares, worth $17.10. The average tenure of the management team and the board of directors is 6.5 years and 9.3 years respectively.

Key information

Clay Shorrock

Chief executive officer

US$300.0k

Total compensation

CEO salary percentage100.00%
CEO tenure4.5yrs
CEO ownership0.0003%
Management average tenure6.5yrs
Board average tenure9.3yrs

Recent management updates

Recent updates

The Market Doesn't Like What It Sees From Applied DNA Sciences, Inc.'s (NASDAQ:APDN) Revenues Yet As Shares Tumble 26%

Dec 20
The Market Doesn't Like What It Sees From Applied DNA Sciences, Inc.'s (NASDAQ:APDN) Revenues Yet As Shares Tumble 26%

Is Applied DNA Sciences (NASDAQ:APDN) In A Good Position To Invest In Growth?

Jan 01
Is Applied DNA Sciences (NASDAQ:APDN) In A Good Position To Invest In Growth?

CEO Compensation Analysis

How has Clay Shorrock's remuneration changed compared to Applied DNA Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2025n/an/a

US$41m

Mar 31 2025n/an/a

US$32m

Dec 31 2024n/an/a

-US$24m

Sep 30 2024US$300kUS$300k

-US$7m

Jun 30 2024n/an/a

-US$7m

Mar 31 2024n/an/a

-US$13m

Dec 31 2023n/an/a

-US$7m

Sep 30 2023US$501kUS$300k

-US$10m

Compensation vs Market: Clay's total compensation ($USD300.00K) is below average for companies of similar size in the US market ($USD607.94K).

Compensation vs Earnings: Clay's compensation has been consistent with company performance over the past year.


CEO

Clay Shorrock (41 yo)

4.5yrs
Tenure
US$300,000
Compensation

Mr. Clay Shorrock, Esq. & J.D., serves as Chief Legal Officer & Executive Director of Business Development at Applied DNA Sciences, Inc. since April 1, 2021 and serves as its President of LineaRx, Inc. fro...


Leadership Team

NamePositionTenureCompensationOwnership
Judith Murrah
Chairperson & Secretaryless than a yearUS$292.06k0.00023%
$ 12.7
Clay Shorrock
President4.5yrsUS$300.00k0.00031%
$ 17.1
Beth Jantzen
Chief Financial Officer10.7yrsUS$300.00k0.00023%
$ 12.7
Sanjay Hurry
Executive Director of Investor Relations & Corporate Communications5.3yrsno datano data
6.5yrs
Average Tenure
49yo
Average Age

Experienced Management: APDN's management team is seasoned and experienced (6.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Judith Murrah
Chairperson & Secretaryless than a yearUS$292.06k0.00023%
$ 12.7
Robert Catell
Chairman of Strategic Advisory Board & Independent Director9.7yrsno data0.000080%
$ 4.4
Yacov Shamash
Independent Director19.6yrsno data0.000080%
$ 4.4
Raymond Kelly
Member of Strategic Advisory Board8.8yrsno datano data
Joseph Ceccoli
Independent Director10.8yrsno data0.000080%
$ 4.4
Sanford Simon
Independent Director19.6yrsno data0%
$ 0
Mehmood Khan
Member of Strategic Advisory Board9yrsno datano data
Gunther Faber
Member of Strategic Advisory Board9.7yrsno datano data
Elizabeth M. Shaheen
Independent Director8.3yrsno data0.000080%
$ 4.4
Stephen Birkhold
Member of Strategic Advisory Board6.8yrsno datano data
9.3yrs
Average Tenure
74yo
Average Age

Experienced Board: APDN's board of directors are considered experienced (9.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/06 09:52
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Applied DNA Sciences, Inc. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jan WaldBenchmark Company
Matthew MillerCFRA Equity Research
Yi ChenH.C. Wainwright & Co.